Agilent Technologies Dirección

Dirección controles de criterios 3/4

El CEO de Agilent Technologies' es Mike McMullen , nombrado en Sep 2014, tiene una permanencia de 9.5 años. compensación anual total es $16.02M, compuesta por 8.2% salario y 91.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.086% de las acciones de la empresa, por valor de MX$596.91M. La antigüedad media del equipo directivo y de la junta directiva es de 6.8 años y 8.5 años, respectivamente.

Información clave

Mike McMullen

Chief Executive Officer (CEO)

US$16.0m

Compensación total

Porcentaje del salario del CEO	8.2%
Permanencia del CEO	9.5yrs
Participación del CEO	0.09%
Permanencia media de la dirección	6.8yrs
Promedio de permanencia en la Junta Directiva	8.5yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Mike McMullen en comparación con los beneficios de Agilent Technologies?
Fecha	Compensación total	Salario	Ingresos de la empresa
Jan 31 2024	n/a	n/a	US$1b
Oct 31 2023	US$16m	US$1m	US$1b
Jul 31 2023	n/a	n/a	US$1b
Apr 30 2023	n/a	n/a	US$1b
Jan 31 2023	n/a	n/a	US$1b
Oct 31 2022	US$17m	US$1m	US$1b
Jul 31 2022	n/a	n/a	US$1b
Apr 30 2022	n/a	n/a	US$1b
Jan 31 2022	n/a	n/a	US$1b
Oct 31 2021	US$16m	US$1m	US$1b
Jul 31 2021	n/a	n/a	US$990m
Apr 30 2021	n/a	n/a	US$925m
Jan 31 2021	n/a	n/a	US$810m
Oct 31 2020	US$14m	US$1m	US$719m
Jul 31 2020	n/a	n/a	US$691m
Apr 30 2020	n/a	n/a	US$683m
Jan 31 2020	n/a	n/a	US$764m
Oct 31 2019	US$13m	US$1m	US$1b
Jul 31 2019	n/a	n/a	US$1b
Apr 30 2019	n/a	n/a	US$1b
Jan 31 2019	n/a	n/a	US$1b
Oct 31 2018	US$12m	US$1m	US$316m
Jul 31 2018	n/a	n/a	US$298m
Apr 30 2018	n/a	n/a	US$237m
Jan 31 2018	n/a	n/a	US$196m
Oct 31 2017	US$10m	US$1m	US$684m

Compensación vs. Mercado: La compensación total de Mike($USD16.02M) está por encima de la media de empresas de tamaño similar en el mercado MX ($USD6.07M).

Compensación vs. Ingresos: La compensación de Mike ha sido consistente con los resultados de la empresa en el último año.

CEO

Mike McMullen (62 yo)

9.5yrs

Permanencia

US$16,023,410

Compensación

Mr. Michael R. McMullen, also known as Mike, is Director at KLA Corporation from July 24, 2023. He is the President of Agilent Technologies, Inc. since September 17, 2014 and Chief Executive Officer since...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael McMullen	CEO, President & Director	9.5yrs	US$16.02m	0.086% $ 596.9m
Robert McMahon	Senior VP	5.5yrs	US$4.81m	0.032% $ 219.8m
Padraig McDonnell	Chief Operating Officer	less than a year	US$3.27m	0.0051% $ 35.4m
Henrik Ancher-Jensen	Senior VP and President of Order Fulfillment & Supply Chain	10.5yrs	US$3.33m	0.0032% $ 22.0m
Rodney Gonsalves	Principal Accounting Officer	8.8yrs	sin datos	0.0089% $ 61.9m
John Kohl	Senior Vice President & Chief Information Officer	8.2yrs	sin datos	sin datos
P. Chiu	VP, Interim General Counsel & Secretary	less than a year	sin datos	sin datos
Dominique Grau	Senior Vice President of Human Resources & Global Communications	9.6yrs	US$2.21m	0.031% $ 217.3m
Allison Ballmer	Senior Vice President of Strategy & Corporate Development	3.2yrs	sin datos	sin datos
Yvonne Mackie	MD of UK & Ireland Operations and VP of Human Resources - Europe	19.2yrs	sin datos	sin datos
Jenipher Dalton	Senior VP	3.3yrs	sin datos	sin datos
Philip Binns	Senior VP of Agilent and President of Life Sciences & Applied Markets Group	less than a year	sin datos	0.0024% $ 16.7m

6.8yrs

Permanencia media

58yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de A * es experimentado (6.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael McMullen	CEO, President & Director	9yrs	US$16.02m	0.086% $ 596.9m
Heidi Fields	Independent Director	24.1yrs	US$347.56k	0.00057% $ 4.0m
Otis Brawley	Independent Director	2.3yrs	US$331.85k	0% $ 0
George Scangos	Independent Director	13.2yrs	US$351.85k	0.0061% $ 42.4m
Dow Wilson	Independent Director	6yrs	US$356.85k	0% $ 0
Boon Hwee Koh	Independent Non-Executive Chairman	20.8yrs	US$486.85k	0.016% $ 108.4m
Daniel Podolsky	Independent Director	8.7yrs	US$341.85k	0% $ 0
Mala Anand	Independent Director	5yrs	US$331.85k	0.0038% $ 26.1m
Mikael Dolsten	Independent Director	2.5yrs	US$357.56k	0.00068% $ 4.7m
Hans Edgar Bishop	Independent Director	6.7yrs	US$331.85k	0% $ 0
Susan Rataj	Independent Director	8.5yrs	US$341.85k	0.0085% $ 59.0m

8.5yrs

Permanencia media

65yo

Promedio de edad

Junta con experiencia: La junta directiva de A * se considera experimentada (8.5 años de antigüedad promedio).

Agilent Technologies Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024

Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group

Recent updates

Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics

Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on July 24, 2024

Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024

Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics

Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency

Agilent Technologies, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on April 24, 2024

Agilent Technologies, Inc. to Report Q1, 2024 Results on Feb 27, 2024

Agilent Technologies, Inc. Announces New Proteoanalyzer System

Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024

Agilent Makes Strategic Updates to Organizational Structure

Agilent Technologies Inc. Announces the Addition of Water Immersion and New Confocal Spinning Disk Technology to the Biotek Cytation C10 Confocal Imaging Reader

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

Agilent Technologies Inc. Increases Quarterly Cash Dividend, Payable on January 24, 2024

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group

Agilent Technologies, Inc. to Report Q4, 2023 Results on Nov 20, 2023

Agilent Technologies, Inc. Announces Quarter Dividend, Payable on October 25, 2023

Exact Sciences Corporation (NasdaqCM:EXAS) agreed to acquire Resolution Bioscience, Inc. from Agilent Technologies, Inc. (NYSE:A).

Agilent Technologies, Inc. Announces Management Changes

Agilent Technologies, Inc. Appoints Philip Binns as President of Life Sciences and Applied Markets Group

Agilent Technologies, Inc. Provides Earnings Guidance for the Year 2023

Agilent Technologies, Inc. to Report Q3, 2023 Results on Aug 15, 2023

Agilent Technologies Inc. Announces the Launch of New Gen6 Software for All Agilent BioTek Detection Instruments

Agilent Technologies Inc. Introduces New Comprehensive GPC/SEC Solutions At HPLC 2023 Conference

Agilent Announces Biotek 406 Fx Washer Dispenser for Technology-Driven Workflow Efficiency

Agilent Technologies, Inc. Provides Earnings Guidance for the Third Quarter and Full Year Ended 2023

Agilent Technologies, Inc. Announces Cash Dividend, Payable on July 26, 2023

Upcoming dividend of US$0.23 per share at 0.7% yield

First quarter 2023 earnings released: EPS: US$1.19 (vs US$0.94 in 1Q 2022)

Agilent Technologies Inc. Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

Agilent Technologies, Inc., Annual General Meeting, Mar 15, 2023

Agilent Technologies, Inc. to Report Q1, 2023 Results on Feb 28, 2023

Agilent Technologies, Inc. (NYSE:A) announces an Equity Buyback for $2,000 million worth of its shares.

Agilent Technologies, Inc. (NYSE : A) acquired Avida Biomed Inc.

Upcoming dividend of US$0.23 per share

Full year 2022 earnings released: EPS: US$4.19 (vs US$3.98 in FY 2021)

Insider recently sold Mex$90m worth of stock

Agilent Technologies, Inc.'s ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer

Independent Non-Executive Chairman recently sold Mex$39m worth of stock

Insider recently sold Mex$38m worth of stock

Principal Accounting Officer recently sold Mex$14m worth of stock

Full year 2022 earnings released: EPS: US$4.19 (vs US$3.98 in FY 2021)

Agilent Technologies, Inc. Provides Revenue Guidance for the First Quarter and Year Full Year 2023

Agilent Technologies Inc. Announces Quarterly Cash Dividend, Payable on January 25, 2023

Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0

Agilent Technologies, Inc. to Report Q4, 2022 Results on Nov 21, 2022

Agilent Technologies Inc. Announces Release of its Enhanced 8700 LDIR Chemical Imaging System for Microplastics Analysis

Insider recently sold Mex$5.3m worth of stock

Agilent Technologies Inc. Announces Quarterly Cash Dividend, Payable on October 26, 2022

Insider recently sold Mex$6.7m worth of stock

Third quarter 2022 earnings released: EPS: US$1.10 (vs US$0.87 in 3Q 2021)

Agilent Technologies, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2022

Agilent Technologies, Inc. (NYSE:A) acquired PSS Polymer Standards Service GmbH.

Agilent Technologies, Inc. to Report Q3, 2022 Results on Aug 16, 2022

Insider recently sold Mex$2.4m worth of stock

Upcoming dividend of US$0.21 per share

Insider recently sold Mex$15m worth of stock

Agilent Technologies, Inc. Announces New Oligonucleotide Analysis Software for Biopharma Research

Agilent Technologies, Inc. Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union

Second quarter 2022 earnings released: EPS: US$0.92 (vs US$0.71 in 2Q 2021)

Agilent Technologies, Inc. Provides Earnings Guidance for the Third Quarter and Fiscal Year 2022

Agilent Technologies, Inc. Provides Earnings Guidance for the Third Quarter and Fiscal Year 2022